Home › T-Cell Lymphoma

T-Cell Lymphoma clinical trials recruiting in the U.S.

35 studies for T-Cell Lymphoma are recruiting participants at sites across the United States.

Cities with the most studies

• New York City, NY13 studies
• Philadelphia, PA10 studies
• Baldwin Park, CA9 studies
• Boston, MA9 studies
• Houston, TX8 studies
• Atlanta, GA7 studies
• Seattle, WA6 studies
• Chicago, IL6 studies
• Rochester, MN6 studies
• Columbus, OH6 studies
• New Haven, CT5 studies
• Miami, FL5 studies
• Charlottesville, VA4 studies
• St. Louis, MO4 studies
• Portland, OR4 studies
• Durham, NC4 studies
• Cedar Rapids, IA4 studies
• Scottsdale, AZ4 studies
• Baltimore, MD4 studies
• Ann Arbor, MI4 studies
• Milwaukee, WI3 studies
• Aurora, CO3 studies
• Cincinnati, OH3 studies
• Staten Island, NY3 studies
• Queens, NY3 studies
• Edison, NJ3 studies
• East Norwalk, CT3 studies
• New Rochelle, NY3 studies
• Denver, CO3 studies
• Charlotte, NC3 studies
• San Diego, CA3 studies
• San Francisco, CA3 studies
• Tampa, FL3 studies
• Omaha, NE3 studies
• Salt Lake City, UT3 studies
• Los Angeles, CA3 studies
• Minneapolis, MN3 studies
• Indianapolis, IN3 studies
• Rochester, NY3 studies
• Madison, WI3 studies

By state

• Arizona5 studies
• California13 studies
• Colorado6 studies
• Connecticut5 studies
• Florida8 studies
• Georgia7 studies
• Illinois7 studies
• Indiana3 studies
• Iowa4 studies
• Maryland4 studies
• Massachusetts9 studies
• Michigan5 studies
• Minnesota9 studies
• Missouri4 studies
• Nebraska3 studies
• New Jersey4 studies
• New York15 studies
• North Carolina6 studies
• Ohio8 studies
• Oklahoma3 studies
• Oregon4 studies
• Pennsylvania12 studies
• Texas9 studies
• Utah3 studies
• Virginia5 studies
• Washington6 studies
• Wisconsin5 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.